Remikiren
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Remikiren is a renin inhibitor under development for the treatment of hypertension (high blood pressure). It was first developed by Hoffmann–La Roche in 1996.[1]
References
- ↑ Richter WF, Whitby BR, Chou RC (1996). “Distribution of remikiren, a potent orally active inhibitor of human renin, in laboratory animals”. Xenobiotica. 26 (3): 243–54. doi:10.3109/00498259609046705. PMID 8730917.
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH